|
|
Build Your Online Product Catalogs?
| Product Name: |
Lenalidomide
|
| Supply Ability: |
500kg |
| Related proudcts |
api, |
| Specifications |
99%+ purity, unknown single impurity<0.1% |
| Price Term: |
according to the customers' request |
| Port of loading: |
|
| Minimum Order |
|
| Unit Price: |
|
|
| Lenalidomide was first approved by the US FDA on Dec 27,2005, then approved by EMA on June 14,2007. It was developed and marketed as Revlimid by Celgene. Lenalidomide is an analogue of thalidomide with immunomodulatory, antiangiogenic, and antineoplastic properties. In multiple myeloma cells, the combination of lenalidomide and dexamethasone synergizes the inhibition of cell proliferation and induction of apoptosis. |
| Company: |
Shenzhen Nexconn Pharmatechs Ltd
|
| Contact: |
Mr. Jason Scorpion |
| Address: |
Rm.1249-1251, Jiaxiye Plaza, No.318 Minzhi Ave., Longhua New Dist |
| Postcode: |
518131 |
| Tel: |
+86-755-89396905 |
| Fax: |
+86-755-22712255 |
| E-mail: |
|
|
|
|
Home
